Maurizio Tala
Overview
Explore the profile of Maurizio Tala including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
9
Citations
129
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Palareti G, Testa S, Legnani C, Dellanoce C, Cini M, Paoletti O, et al.
Blood Adv
. 2024 Jun;
8(18):4913-4923.
PMID: 38842448
Treatment with direct oral anticoagulants (DOACs) in patients with atrial fibrillation (AF) is effective and safe. However, bleeding complications still occur. Whether DOAC level measurement may further improve treatment efficacy...
2.
Testa S, Palareti G, Legnani C, Dellanoce C, Cini M, Paoletti O, et al.
Blood Adv
. 2024 Feb;
8(8):1846-1856.
PMID: 38394387
Although effective and safe, treatment with direct oral anticoagulants (DOAC) in atrial fibrillation (AF) is still associated with thrombotic complications. Whether the measurement of DOAC levels may improve treatment efficacy...
3.
Giorgi-Pierfranceschi M, Paoletti O, Pan A, DE Gennaro F, Nardecchia A, Morandini R, et al.
Intern Emerg Med
. 2020 Aug;
15(8):1425-1433.
PMID: 32840805
The association between coronavirus disease 2019 (COVID-19) pneumonia and venous thrombotic disorders is still unclear. We assessed the association between COVID-19 infection-related pneumonia and proximal deep-vein thrombosis (DVT) in a...
4.
Coppola A, Lombardi M, Tassoni M, Carolla G, Tala M, Morandini R, et al.
Blood Transfus
. 2020 May;
18(3):226-229.
PMID: 32453688
No abstract available.
5.
Testa S, Prandoni P, Paoletti O, Morandini R, Tala M, Dellanoce C, et al.
J Thromb Haemost
. 2020 Apr;
18(6):1320-1323.
PMID: 32329231
Background: Antiviral drugs are administered in patients with severe COVID-19 respiratory syndrome, including those treated with direct oral anticoagulants (DOACs). Concomitant administration of antiviral agents has the potential to increase...
6.
Tosetto A, Testa S, Palareti G, Paoletti O, Nichele I, Catalano F, et al.
Intern Emerg Med
. 2019 Jul;
14(8):1307-1315.
PMID: 31309520
The primary study objective is to compare the outcomes of patients taking oral anticoagulant medications in two distinct populations treated according to different management models (comprehensive vs. usual care). (Design:...
7.
Dabigatran Plasma Measurement to Guide the Management of Acute Bleeding and Thrombotic Complications
Tala M, Paoletti O, Dellanoce C, Morandini R, Valtulina C, Sessa M, et al.
Eur J Case Rep Intern Med
. 2019 Feb;
5(9):000947.
PMID: 30756068
Learning Point: Direct oral anticoagulants (DOACs) have been used in clinical practice at fixed doses without laboratory monitoring.However, the importance of measuring DOAC anticoagulant activity to support treatment decisions, particularly...
8.
Testa S, Dellanoce C, Paoletti O, Cancellieri E, Morandini R, Tala M, et al.
Thromb Res
. 2019 Feb;
175:61-67.
PMID: 30721819
Background: High inter-individual variability of the anticoagulant plasma levels of the first three direct oral anticoagulants was previously reported. Aims of the present study were to evaluate edoxaban inter and...
9.
Sotgiu A, Tala M, Sardu G, Coroneo V, Dessi S, Contu P
Ig Sanita Pubbl
. 2007 Jan;
61(5):475-96.
PMID: 17206218
Unlabelled: The development of GM foods and organisms has concentrated everyone's attention on the importance of food safety and on protecting citizens' health, and inevitably influenced healthcare policies regarding food...